Huss, A.; Abdelhak, A.; Mayer, B.; Tumani, H.; Müller, H.-P.; Althaus, K.; Kassubek, J.; Otto, M.; Ludolph, A.C.; Yilmazer-Hanke, D.;
et al. Association of Serum GFAP with Functional and Neurocognitive Outcome in Sporadic Small Vessel Disease. Biomedicines 2022, 10, 1869.
https://doi.org/10.3390/biomedicines10081869
AMA Style
Huss A, Abdelhak A, Mayer B, Tumani H, Müller H-P, Althaus K, Kassubek J, Otto M, Ludolph AC, Yilmazer-Hanke D,
et al. Association of Serum GFAP with Functional and Neurocognitive Outcome in Sporadic Small Vessel Disease. Biomedicines. 2022; 10(8):1869.
https://doi.org/10.3390/biomedicines10081869
Chicago/Turabian Style
Huss, André, Ahmed Abdelhak, Benjamin Mayer, Hayrettin Tumani, Hans-Peter Müller, Katharina Althaus, Jan Kassubek, Markus Otto, Albert C. Ludolph, Deniz Yilmazer-Hanke,
and et al. 2022. "Association of Serum GFAP with Functional and Neurocognitive Outcome in Sporadic Small Vessel Disease" Biomedicines 10, no. 8: 1869.
https://doi.org/10.3390/biomedicines10081869
APA Style
Huss, A., Abdelhak, A., Mayer, B., Tumani, H., Müller, H.-P., Althaus, K., Kassubek, J., Otto, M., Ludolph, A. C., Yilmazer-Hanke, D., & Neugebauer, H.
(2022). Association of Serum GFAP with Functional and Neurocognitive Outcome in Sporadic Small Vessel Disease. Biomedicines, 10(8), 1869.
https://doi.org/10.3390/biomedicines10081869